Filter
204
Text search:
African
Trypanosomiasis
Featured
Recommendations
22
New Publications
33
Language
Document type
Studies & Reports
66
No document type
61
Manuals
18
Guidelines
18
Strategic & Response Plan
13
Resource Platforms
9
Dashboards/Maps
6
Training Material
5
Brochures
3
Videos
2
Fact sheets
2
Situation Updates
1
Countries / Regions
Global
19
Africa
13
Uganda
8
Liberia
7
West and Central Africa
6
East and Southern Africa
5
Sierra Leone
4
Ghana
4
South Sudan
4
Zambia
4
Congo, Democratic Republic of
3
Kenya
3
Malawi
3
Guinea
2
India
2
Chad
2
Tanzania
2
Rwanda
2
South Africa
2
Angola
2
Middle East and North Africa
2
Latin America and the Carribbean
2
Nigeria
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Syria
1
Sudan
1
Benin
1
Botswana
1
El Salvador
1
Libya
1
Yemen
1
Palestine
1
Djibouti
1
Southern Africa
1
Qatar
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
20
Public Health
17
Capacity Building
6
Pharmacy & Technologies
6
Key Resources
5
Women & Child Health
2
Toolboxes
NTDs
104
Planetary Health
11
Rapid Response
7
Malaria
6
Ebola & Marburg
4
Mental Health
3
Pharmacy
3
NCDs
3
2.0 Rapid Response
3
TB
2
AMR
2
Disability
1
Natural Hazards
1
HIV
1
COVID-19
1
Caregiver
1
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei
...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies
...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT)
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human
...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caus
...
More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form)
Human
...
The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to dea
...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discove
...
MSD Manual Professional Version
MSD Manual Consumer Version
Learning sheet no. 4
Accessed March, 2025
Video.
Lesson on African Trypanosomiasis (African Sleeping Sickness): Causes, Symptoms and Treatment.
...
Human African trypanosomiasis (HAT), or sleeping sickness, is caused by trypanosome parasites that are transmitted by tsetse flies. HAT is found only in sub-Saharan Africa. Two subspecies of Trypano
...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underd
...
Human African trypanosomiasis (HAT) is a lethal neglected tropical disease (NTD) transmitted by the bite of infected tsetse flies. The disease is also known as “sleeping sickness”. During the 20
...
Resource Platform
Chapter in Clinical guidelines -Diagnosis and Treatment manual
PLoS Negl Trop Dis 16(11): e0010885. https://doi.org/10.1371/journal.pntd.0010885
HAT diagnosis in non-endemic countries is rare and can be challenging, but alertness and
surveillance must be maintained to contribute to WHO’s elimination goals. Early detection is
particularly important as it co
...
Weekly epidemiological record.
Chad was validated for the elimination of gambiense HAT as a public health problem in April 2024, and the work continues towards interrupting transmission further.
